Signed in as:
filler@godaddy.com
Improving the experience for pharmacy customers is our top priority.
Introducing the innovative MEDRiGHT cap: a thoughtful prescription management system for retail pharmacy vials. This compassionate solution features fluorescent icons for the sun/moon or AM/PM as a secondary visual aid while in use. The dispenser is designed to be easy to handle, especially for those with rheumatoid arthritis, and includes a built-in safety tab to significantly reduce prescription errors, ensuring peace of mind for both patients and healthcare providers.
Elimination the everyday of opening and closing pharmacy vials Streamline the process by eliminating the need to open and close pharmacy vials every day.
We highly esteem the Arthritis Foundation of America and the Alzheimer's Foundation of America. Our daily efforts are committed to making a significant impact and improving the quality of life for many individuals. It is crucial to emphasize that a portion of the proceeds from the sales of the MEDRIGHT dispenser system will be directed to these two foundations to contribute to ongoing research aimed at finding a cure.
Arthritis is Osteoarthritis & Rheumatoid arthritis.
• 1-5 Adults (21.2%) or about 53.2 million people have been clinically diagnosed with Arthritis and more common in Woman @ 20.9% vs Men @ 16.3% in the U.S.
• U.S. Veterans have an alarming rate of 24.2% then non-Veterans at 18.5% and more than half of the U.S. adults (51.7%) with Arthritis are of working age (18 to 64 years) which creates limits to their everyday.
The United States will see the largest increases in Alzheimer’s disease and related dementias between 2015 and 2020.
Dementia is not a specific disease but rather a general term for the impaired ability to remember, think, or make decisions that interfere with everyday activities.
Alzheimer’s disease is the most common type of dementia. Current estimates are that about 5.8 million people in the United States have Alzheimer’s disease and related dementias, including 5.6 million aged 65 and older and about 200,000 under age 65 with younger-onset Alzheimer’s. By 2060, the number of Alzheimer’s disease cases is predicted to rise to an estimated 14 million people.